Published in

Elsevier, Data in Brief, (4), p. 468-473, 2015

DOI: 10.1016/j.dib.2015.06.024

Links

Tools

Export citation

Search in Google Scholar

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Journal article published in 2015 by Teresa Núñez de Villavicencio-Díaza, Sabina Victoriae, Teresa Núñez de Villavicencio-Díaz, Yassel Ramos Gómez, Yassel Ramos Gómeza, Brizaida Oliva Argüelles, Yassel Ramos Gómez, Brizaida Oliva Argüelles, Brizaida Oliva Argüellesb, Julio R. Fernández Masso, Arielis Rodríguez-Ulloa, Yiliam Cruz García, Yiliam Cruz García, Yiliam Cruz Garcíac, Osmany Guirola-Cruz and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above analysis.